Type 1 insulin-like growth factor signalling in malignant melanoma
<p>Novel therapeutic strategies are sorely required for malignant melanoma, which has been shown to overexpress the type 1 insulin-like growth factor receptor (IGF1R) compared to benign naevi. The IGF1R mediates many features of the malignant phenotype and is an attractive anti-cancer therapeu...
| Príomhchruthaitheoirí: | , |
|---|---|
| Rannpháirtithe: | |
| Formáid: | Tráchtas |
| Teanga: | English |
| Foilsithe / Cruthaithe: |
2012
|
| Ábhair: |